Executive Collapses During Oval Office Press Conference
Gordon Findlay, a Novo Nordisk executive, dramatically collapsed while standing behind President Donald Trump during a White House press event. The conference announced a new deal related to weight-loss medications.
Incident Details
Suddenly, Findlay's knees buckled, causing him to fall. Administration officials and pharmaceutical representatives quickly intervened to prevent him from hitting the floor.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.” — White House Press Secretary Karoline Leavitt
Response from Officials
Dr. Mehmet Oz, Administrator for Centers for Medicare & Medicaid Services, assisted Findlay in safely lowering him to the ground to avoid head injury. Following the collapse, reporters were guided out of the Oval Office while cabinet members attended to Findlay and elevated his legs.
Press Conference Resumption
According to Karoline Leavitt, medics on site confirmed that Findlay was alright, and the press conference resumed shortly after the incident.
Summary
During a Trump administration announcement on weight-loss drug deals, a Novo Nordisk executive fainted but received prompt medical attention, allowing the event to continue without further disruption.
Author's summary: A top pharmaceutical executive fainted during a White House event but quickly recovered thanks to immediate medical aid, highlighting the intensity of high-profile announcements.